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  Although various derivatives of caffeic acid have been reported to possess a wide variety of biological 
activities such as neuronal protection against excitotoxicity and anti-inflammatory property, the 
biological activity of 3,4,5-trihydroxycinnamic acid (THC), a derivative of hydroxycinnamic acids, has 
not been clearly examined. The objective of the present study is to evaluate the anti-inflammatory 
effects of THC on lipopolysaccharide (LPS)-stimulated BV2 microglial cells. THC significantly 
suppressed LPS-induced excessive production of nitric oxide (NO) and expression of iNOS, which is 
responsible for the production of iNOS. THC also suppressed LPS-induced overproduction of 
pro-inflammatory cytokines such as IL-1βand TNF-αin BV2 microgilal cells. Furthermore, THC 
significantly suppressed LPS-induced degradation of IκB, which retains NF-κB in the cytoplasm. 
Therefore, THC attenuated nuclear translocation of NF-κB, a major pro-inflammatory transcription 
factor. Taken together, the present study for the first time demonstrates that THC exhibits anti- 
inflammatory activity through the suppression of NF-κB transcriptional activation in LPS-stimulated 
BV2 microglial cells.
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INTRODUCTION
  Microglia are resident immune cells in the central nervous 
system that respond to extracellular stimuli and play a cru-
cial role in host defense and tissue repair in brain [1,2]. 
However, aberrant activation of microglia has also been pro-
posed to play a pathogenic role in neuro-inflammatory con-
ditions such as ischemia, multiple sclerosis, Parkinson’s dis-
ease and Alzheimer’s disease [3-6]. Under these CNS disease 
conditions, activated microglia have been suggested to con-
tribute to neurodegenerative process by producing pro-in-
flammatory mediators such as NO and several cytokines 
such as tumor necrosis factor-α(TNF-α), interleukin-1β
(IL-1β) [7-10]. Therefore, suppression of aberrant microglial 
activation may have valuable therapeutic potential for the 
treatment of inflammatory diseases in the CNS caused by 
activated microglia.
  3,4,5-Trihydroxycinnamic acid (THC) is a derivative of 
hydroxycinnamic acids. Hydroxycinnamic acids have been 
reported to possess a wide variety of biological properties 
such as anti-inflammatory, anti-tumor, and neuroprotective 
activities [11-13]. Ester derivatives of hydroxycinnamic 
acids have been also reported to exhibit various biological 
activities [14]. Furthermore, it has been also reported that 
CAPE, caffeic acid phenylethyl ester, inhibits cytokine- 
mediated NF-κB activation in murine macrophage cells 
[15]. Although THC was previously identified in Rooibos 
tea (Aspalathus linearis) [16], its biological activity has not 
been extensively examined. Recently, it has been reported 
that THC inhibits human neutrophil elastase, which causes 
degradation of healthy tissues contributing to inflammatory 
diseases such as rheumatoid arthritis and psoriasis [11].
  In the present study, in order to provide a novel pharma-
cological agent that could suppress abnormally activated 
microglia, the anti-inflammatory activity of THC, a deriva-
tive of hydroxycinnamic acids, and its underlying mecha-
nism were examined in LPS-stimulated BV2 microglial 
cells.108 JW Lee, et al
Fig. 1. Chemical structure of 3,4,5-Trihydroxycinnamic acid (THC).
METHODS
Reagents and cell culture
  Bacterial lipopolysaccharide (LPS) from Escherichia coli 
serotype 055:B5 was purchased from Sigma-Aldrich (St. 
Louis, MO, USA). 3,4,5-Trihydroxycinnamic aicd (THC) 
(Fig. 1) was purchased from AApin Chemicals Limited 
(Abingdon, UK). The compound was solubilized in dimethyl 
sulfoxide (DMSO) and added to the cell culture at the de-
sired concentrations. The BV2 microglial cell line was main-
tained in Dulbecco's modified Eagle's medium (DMEM; 
Gibco BRL, Grand Island, NY, USA) containing 5% heat-in-
activated fetal bovine serum (FBS; Gibco BRL) and 50μg/ml 
gentamicin (Sigma, St. Louis, MO, USA) at 37
oC, 5% CO2. 
In all experiments, cells were incubated in the presence of 
the indicated concentration of THC before the addition of 
LPS (200 ng/ml).
Cell viability
  Cell viability was determined by 3-(4,5-dimethylthiazol- 
2-yl)-2,5-diphenyltetrazolium bromide (MTT) assay. In brief, 
cells (5×10
5) were seeded in 12 well plates and treated with 
various concentrations of THC for 24 hr. MTT (0.5 mg/ml 
in PBS) was added to each well, and the cells were in-
cubated for 3 hr at 37
oC and 5% CO2. The resulting for-
mazan crystals were dissolved in dimethyl sulfoxied 
(DMSO). Absorbance was determined at 540 nm. The re-
sults were expressed as a percentage of surviving cells over 
control cells. 
Nitrite quantification assay
  The production of NO was estimated by measuring the 
amount of nitrite, a stable metabolite of NO, using the 
Griess reagent as described [14]. After THC-pretreated BV2 
microglial cells were stimulated with LPS in 12-well plates 
for 24 hr, and then 100 μl of the cell culture media was 
mixed with an equal volume of Griess reagent. Light ab-
sorbance was read at 540 nm. The results were expressed 
as a percentage of released NO from LPS-stimulated BV2 
cells. To prepare a standard curve, sodium nitrite was used 
to prepare a standard curve. 
TNF-αand IL-1β ELISA
  The BV2 microglial cells were treated with THC in the 
absence or presence of LPS. After 24 hr incubation, TNF-α 
and IL-1β levels in culture media were quantified using 
monoclonal anti-TNF-α or IL-1β antibodies according to 
the manufacturer’s instruction (R&D Systems).
Western blot analysis
  The BV2 microglial cells were pretreated with THC for 
1 hr and stimulated with LPS. Cells were washed with PBS 
and lysed with lysis buffer [50 mM Tris-HCl, pH 8.0, 150 
mM NaCl, 0.02% sodium azide, 0.1% sodium dodecyl sulfate 
(SDS), 1% NP-40, 0.5% sodium deoxycholate, 1 mM phenyl 
methylsulfonyl fluoride]. Equal amounts of protein were 
separated on 10% SDS-polyacrylamide gel. Proteins were 
transferred to Hypond PVDF membrane (Amersham 
Biosciences, Piscataway, NJ, USA) and blocked in 5% skim 
milk in TBST for 1 hr at room temperature. Specific anti-
bodies against inducible NO synthase (iNOS), IκB-α (1：
1,000; Santa Cruz Biotechnology Inc) and β-actin (1：
2,500; Sigma) were diluted in 5% skim milk. After thor-
oughly washing with TBST, horseradish peroxidase-con-
jugated secondary antibodies were applied. The blots were 
developed by the enhanced chemiluminescence detection 
(Amersham Biosciences). 
RNA isolation and Reverse transcription-polymerase 
chain reaction (RT-PCR)
  The BV2 microglial cells were treated with THC in the ab-
sence or presence of LPS (200 ng/ml) for 6 h. Total RNA was 
isolated using the Total RNA Extraction Kit (iNtRON 
Biotechnology, Inc, USA) according to the manufacturer's 
instruction. The total RNA (2 μg) obtained from cells was 
reverse-transcribed using oligo-(dT) 15 primers (Promega, 
Madison, WI, USA). PCR amplification conditions using pri-
mer sets specific for iNOS, TNF-α, IL-1β and β-actin were 
optimized for each pair of primers. PCR primers were as fol-
lows: mouse iNOS forward, 5'-CCCTTC CGAAGTTTCTGGC-
AGCAG C-3'; iNOS reverse, 5'-GGCTGTCAGAGCCTCG-
TGGCTTTG G-3'; TNF-α forward, 5'-CATCTTCTCAAAA-
TTCGAGTGACAA-3'; TNF-α reverse, 5'-ACTTGGGC AGA-
TTGACCTCA G-3'; IL-1β forward, 5'-GCAACTGTTCCTG-
AACTC-3'; IL-1β reverse, 5'-CTCGGAGCCTG TAGTGCA-3'; 
β-actin forward, 5'-ATCCTGA AAGACCTCTATGC-3'; β-actin 
reverse, 5'-AACGCAGCTCAGTAACAGTC-3'. Parallel PCR 
analysis was run for the house keeping gene β-actin to nor-
malize data for differences in mRNA quantity and integrity. 
PCR products were separated on agarose gel.
Immunofluorescence assay
  The BV2 microglial cells were cultured in sterile cover-
slips and pretreated with THC for 1 hr and stimulated with 
LPS. After 30 min, the cells were fixed in 4% paraformalde-
hyde for 20 min at room temperature. The fixed cells were 
then permeabilized with 0.1% Triton X-100 in PBS and 
blocked with 3% BSA. Afterwards, the cells were sequen-
tially incubated with rabbit anti-p65 antibody (1 : 100; 
Santa Cruz Biotechnology Inc) at room temperature and 
Alexa 546-labeled goat anti-rabbit IgG (Molecular Probes, 
Eugene, OR, USA) at room temperature for 1 hr. Cells were 
washed with PBS, and then stained with 0.5μg/ml of 
Hoechst staining solution for 10 min at room temperature. 
After washing with PBS, the coverslips were mounted and 
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Fig. 2. THC inhibited NO production (A) and expression levels of iNOS protein (B) and mRNA (C) in LPS-stimulated BV2 microglial cells. 
(A) BV2 cells were pretreated with various concentrations of THC for 1 hr before incubation with LPS (200 ng/ml) for 24 hr. The amounts 
of nitrite in the supernatants were measured using Griess reagent. THC exhibited a significant suppression of LPS- induced NO production 
in a concentration-dependent manner. (B) The cell lysates were subjected to SDS-PAGE, and then protein levels of iNOS were determined 
by Western blot analysis. (C) After LPS treatment for 6 hr, total mRNA levels of iNOS were examined by RT-PCR. The β-actin was used 
as an internal control. Quantification of iNOS production was performed by densitometric analysis (lower). THC significantly suppressed 
LPS-induced iNOS expression in a concentration-dependent manner. The data are expressed as mean±S.D. (n=3), and are representative 
of three or more independent experiments. *p＜0.05, **p＜0.01 and ***p＜0.001 indicate statistically significant differences from treatment 
with LPS alone.
Statistical analysis
  All values shown in the figures are expressed as the 
mean±SD obtained from at least three independent experi-
ments. Statistical analysis was carried out by one-way 
analysis of variance (ANOVA) with Tukey's post-hoc test 
using SPSS software 12K (SPSS, Chicago, IL, USA). A val-
ue of p＜0.05 was considered as statistically significant.
RESULTS
THC suppresses NO production in LPS-stimulated 
BV2 microglial cells
  Based on that NO production has been widely used as 
a representative measure of inflammatory activation of mi-
croglia [17], we measured suppressive effects of THC on NO 
production in LPS-stimulated BV2 microglial cells. Cells 
were incubated with indicated concentrations of THC (0, 
0.1, 1, 10, 25, 50 or 100μM) for 1 hr prior to LPS treatment 
and Griess reaction was used as an index for NO synthesis. 
As shown in Fig. 2A, LPS markedly increased NO pro-
duction in BV2 microglial cells. However, THC significantly 
inhibited NO production in LPS-stimulated BV2 micgroglia 
cells in a concentration dependent manner (Fig. 2A). In ad-
dition, THC showed no significant cytotoxicity in concen-
tration ranges, in which THC exhibits suppressive activity 
of NO production, irrespective of LPS presence (data not 
shown).
THC inhibits LPS-induced mRNA and protein expres-
sion of iNOS
  As THC was found to inhibit NO production in Fig. 2A, 
we examined the mRNA and protein expression levels of 
iNOS upon THC treatment, using RT-PCR and Western 
blot analyses, respectively. LPS resulted in markedly in-
creased expression of iNOS protein, which was significantly 
suppressed with THC treatment in a concentration-depend-
ent manner (Fig. 2B). Consistent with the decrease of iNOS 
protein, THC also significantly attenuated LPS-induced 
up-regulation of iNOS mRNA expression (Fig. 2C). These 
results demonstrate that THC possesses significant in-
hibitory effects on LPS-induced expression of iNOS, which 
is considered as a major source of cytotoxic NO.
THC attenuates LPS-induced gene expression and 
release of pro-inflammatory cytokines
  To examine the effects of THC on TNF-α and IL-1βgene 
expression at the transcriptional level, RT-PCR was per-
formed in the LPS-stimulated BV2 microglial cells. THC 
significantly suppressed LPS-induced expression of these 
genes in a concentration-dependent manner (Fig. 3A). In 
accordance with the change in gene expression of cytokines, 
THC resulted in a significant suppression of LPS-induced 
extracellular release of these cytokines (Fig. 3B).
THC attenuates nuclear translocation of NF-κB via 
suppression of LPS-induced IKB degradation
  Given the previous report that the transcription factor 
NF-κB is a predominant regulator of iNOS and numerous 
pro-inflammatory genes [17,18] and that IκB inhibits the 
nuclear translocation of p65 subunit of NF-κB, we inves-
tigated whether THC inhibits LPS-induced nuclear trans-
location of NF-κB and degradation of cytosolic IκB. THC 
blocked LPS-induced degradation of IκB in a concen-
tration-dependent manner (Fig. 4). The cellular localization 
of p65 was investigated by immunofluorescence staining. 
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Fig. 3. THC inhibited gene expression (A) and release (B) of TNF-α and IL-1β in LPS-stimulated BV2 microglial cells. (A) BV2 microglia 
cells were pretreated with the indicated concentrations of THC for 1 hr before LPS treatment (200 ng/ml), and total RNA was isolated at 
6 hr after LPS treatment and mRNA levels were determined by RT-PCR analysis. THC significantly suppressed expression of TNF-α and 
IL-1β. Data from triplicate determination are shown (mean±SD). (B) Cell culture media were collected and subjected to TNF-α and IL-1β
ELISA. Data represent three independent experiments in triplicate and are expressed as mean±SD. *p＜0.05 and **p＜0.01 indicate statistically
significant differences from treatment with LPS alone. 
##p＜0.01 indicates statistically significant differences between indicated groups.
Fig. 4. Inhibitory effects of THC on LPS-induced IκB-α degration 
in BV2 microlial cells. Total cell lysates obtained 15 min after the 
LPS stimulation were subjected to Western blotting to assess the 
levels of IκB-α degradation (top). Quantification of IκB-α degrada-
tion was performed by densitometric analysis (lower). The β-actin 
was used as an internal control. Data from triplicate determination 
are shown (mean±S.D.). *p＜0.05 and **p＜0.01 indicate statisti-
cally significant differences from treatment with LPS alone.
Fig. 5. THC suppressed the nuclear localization of NF-κB in LPS- 
stimulated BV2 microglial cells. (A) BV2 microglia cells were 
pretreated with THC for 1 hr prior to stimulation with 200 ng/ml 
LPS for 1 hr. Localization of NF-κB p65 subunit was determined 
using an anti-p65 antibody and an Alexa 546-labeled goat anti-rabbit 
IgG antibody. Nuclei were visualized by Hoechst staining. Cells were 
visualized using confocal scanning microscopy. Scale bar=20 μm. (B) 
NF-κB localization was further examined by line scannin.
Nuclear accumulation of p65 was strongly induced after 
stimulation of BV2 microglial with LPS (Fig. 5A). However, 
pretreatment of THC exhibited a significant attenuation of 
LPS-induced nuclear translocation of p65. Line scanning 
analysis of confocal images clearly demonstrated the in-
tensity of intracellular localization of p65 subunit (Fig. 5B). 
These results clearly indicate that THC suppresses LPS-in-
duced NF-κB activation in BV2 microglial cells.Anti-Inflammatory Effects of 3,4,5-Trihydroxycinnamic Acid 111
DISCUSSION
  The present study clearly demonstrated that THC ex-
hibits anti-inflammatory activity in LPS-stimulated BV2 
microglial cells. THC significantly suppressed LPS-induced 
production of NO, upregulation of iNOS expression, and re-
lease of pro-inflammatory cytokines such as TNF-αand 
IL-1β. Furthermore, THC significantly attenuated LPS-in-
duced IκB degradation and consequent nuclear trans-
location of NF-κB, a pro-inflammatory transcription factor.
  Phenylpropanoids are a group of plant-derived secondary 
metabolites that are biosynthesized from phenylalanine to 
coumaric acid and other acids including caffeic acid, ferulic 
acid, and trihydroxycinnamic acid. Hydroxycinnamic acids 
and their ester derivatives have been reported to possess 
a broad spectrum of pharmacological activities including 
antitumor, antiviral, anti-inflammatory, immunosuppre-
ssive, and neuroprotective activities [12-14]. Although it 
has been, recently, reported that chemically synthesized 
THC exerts inhibitory activity against human neutrophil 
elastase, which is involved in the regulation of infla-
mmatory processes [11], the biological properties of THC 
have not been compared to those of other hydroxycinnamic 
acids. In the present study, anti-inflammatory activities of 
THC, originally present in Aspalathus linearis [16], was ex-
amined in comparison with caffeic acid, a prototype hydrox-
ycinnamic acid. Both THC and caffeic acid showed sig-
nificant suppression of LPS-induced NO production in BV2 
microglial cells (Fig. 2A). However, THC exhibited sig-
nificantly greater suppression on LPS-induced NO pro-
duction compared to caffeic acid. Furthermore, THC 
showed suppression in a concentration-dependent manner.
  Aberrant activation of microglia has been reported to con-
tribute to neuronal damage in several pathologic conditions 
by releasing pro-inflammatory mediators such as TNF-α, 
IL-1βand NO [19,20]. Accordingly, suppression of micro-
glial activation and subsequent release of cytokines have 
been demonstrated to protect neuronal damage in several 
inflammation-related CNS diseases [3,21,22]. The present 
study clearly showed that THC suppresses LPS-induced ex-
pression of TNF-α and IL-1β and their extracellular 
release. However, effects of THC on other pro-inflammatory 
cytokines have not been examined. Therefore, further stud-
ies are necessary to examine the effect of THC on the re-
lease and gene expression of other cytokines. In addition, 
the present study showed that THC significantly sup-
pressed LPS-induced NO production, a well-known pro-in-
flammatory mediator, through the suppression of iNOS 
gene expression.
  NF-κB is an important transcription factor for pro-in-
flammatory mediators such as iNOS, IL-1β and TNF-α 
[23,24] and inappropriate regulation of NF-κB and its 
downstream genes have been associated with various 
pathological conditions including cancer and autoimmune 
diseases [25,26]. It has been reported that LPS causes the 
nuclear translocation of p65 subunit of NF-κB through Iκ
B degradation [27,28]. In accordance with these reports, the 
present study showed that THC significantly attenuated 
LPS-induced IκB degradation and consequent nuclear 
translocation of p65 in LPS-induced BV2 microglial cells 
(Fig. 5A).
  In conclusion, the results clearly demonstrate that THC 
possesses anti-inflammatory activity such as suppression 
of NO production and cytokine release by inhibiting nuclear 
transclocation of NF-κB in LPS-stimulated BV2 microglial 
cells. The present study strongly suggests that THC might 
be a valuable therapeutic agent in the treatment of in-
flammation-related brain pathologies such as ischemia and 
neurodegenerative diseases. Due to the lack of reports on 
THC, although no noticeable cytotoxic property of THC was 
observed in the concentration ranges used in the present 
study, further studies are necessary to extensively detect 
any possible toxicities of THC. This endeavor could enhance 
the possibility of THC for therapeutic application.　
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